These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 18324972

  • 1. Increased CD177 (PRV1) expression in thalassaemia and the underlying erythropoietic activity.
    Zoi K, Terpos E, Zoi C, Loukopoulos D.
    Br J Haematol; 2008 Apr; 141(1):100-4. PubMed ID: 18324972
    [Abstract] [Full Text] [Related]

  • 2. Analysis of CD177 neutrophil expression in β-thalassemia patients.
    Montaser LM, El-Rashidi FH, Essa ES, Azab SM.
    APMIS; 2011 Oct; 119(10):674-80. PubMed ID: 21917004
    [Abstract] [Full Text] [Related]

  • 3. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L, Giona F, Martini M, Cenci T, Guidi F, Torti L, Palumbo G, Amendola A, Foà R, Larocca LM.
    J Clin Oncol; 2007 Mar 20; 25(9):1048-53. PubMed ID: 17369568
    [Abstract] [Full Text] [Related]

  • 4. Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia.
    Tefferi A, Sirhan S, Lasho TL, Schwager SM, Li CY, Dingli D, Wolanskyj AP, Steensma DP, Mesa R, Gilliland DG.
    Br J Haematol; 2005 Oct 20; 131(2):166-71. PubMed ID: 16197445
    [Abstract] [Full Text] [Related]

  • 5. The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera.
    Johansson P, Ricksten A, Wasslavik C, Johansson B, Andréasson B.
    Haematologica; 2004 Oct 20; 89(10):1264-6. PubMed ID: 15477215
    [Abstract] [Full Text] [Related]

  • 6. The effect of the JAK2 V617F mutation on PRV-1 expression.
    Mnjoyan Z, Yoon D, Li J, Delhommeau F, Afshar-Kharghan V.
    Haematologica; 2006 Mar 20; 91(3):411-2. PubMed ID: 16503546
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders.
    Passamonti F, Pietra D, Malabarba L, Rumi E, Della Porta MG, Malcovati L, Bonfichi M, Pascutto C, Lazzarino M, Cazzola M.
    Br J Haematol; 2004 Sep 20; 126(5):650-6. PubMed ID: 15327515
    [Abstract] [Full Text] [Related]

  • 8. Familial polycythemia vera with non-germline JAK2(V617F) mutation sparing the abnormal and clonal granulopoiesis.
    Hussein K, Bock O, Ballmaier M, Göhring G, Steinemann D, Lehmann U, Kemper J, Buhr T, Kreipe H.
    Leukemia; 2007 Dec 20; 21(12):2566-8. PubMed ID: 17625610
    [No Abstract] [Full Text] [Related]

  • 9. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ, Bernema Z, Van Bockstaele D, De Raeve H, Schroyens W.
    Pathol Biol (Paris); 2007 Mar 20; 55(2):92-104. PubMed ID: 16919893
    [Abstract] [Full Text] [Related]

  • 10. PRV-1 mRNA expression discriminates two types of essential thrombocythemia.
    Griesshammer M, Klippel S, Strunck E, Temerinac S, Mohr U, Heimpel H, Pahl HL.
    Ann Hematol; 2004 Jun 20; 83(6):364-70. PubMed ID: 15034760
    [Abstract] [Full Text] [Related]

  • 11. Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?
    Teofili L, Foà R, Giona F, Larocca LM.
    Haematologica; 2008 Feb 20; 93(2):169-72. PubMed ID: 18245648
    [No Abstract] [Full Text] [Related]

  • 12. Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils.
    Bauer S, Abdgawad M, Gunnarsson L, Segelmark M, Tapper H, Hellmark T.
    J Leukoc Biol; 2007 Feb 20; 81(2):458-64. PubMed ID: 17077162
    [Abstract] [Full Text] [Related]

  • 13. Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes.
    Camaschella C, Gonella S, Calabrese R, Vischia F, Roetto A, Graziadei G, Mazza U, Cappellini MD.
    Haematologica; 1996 Feb 20; 81(5):397-403. PubMed ID: 8952151
    [Abstract] [Full Text] [Related]

  • 14. The gene overexpressed in polycythemia rubra vera, PRV-1, and the gene encoding a neutrophil alloantigen, NB1, are alleles of a single gene, CD177, in chromosome band 19q13.31.
    Caruccio L, Bettinotti M, Director-Myska AE, Arthur DC, Stroncek D.
    Transfusion; 2006 Mar 20; 46(3):441-7. PubMed ID: 16533288
    [Abstract] [Full Text] [Related]

  • 15. Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression.
    Abdgawad M, Gunnarsson L, Bengtsson AA, Geborek P, Nilsson L, Segelmark M, Hellmark T.
    Clin Exp Immunol; 2010 Jul 01; 161(1):89-97. PubMed ID: 20491791
    [Abstract] [Full Text] [Related]

  • 16. Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera.
    Cario H, Schwarz K, Herter JM, Komrska V, McMullin MF, Minkov M, Niemeyer C, Pospisilova D, Reinhard H, Debatin KM, Pahl HL.
    Br J Haematol; 2008 Aug 01; 142(4):622-6. PubMed ID: 18557746
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic control of PRV-1 expression on neutrophils.
    Jelinek J, Li J, Mnjoyan Z, Issa JP, Prchal JT, Afshar-Kharghan V.
    Exp Hematol; 2007 Nov 01; 35(11):1677-83. PubMed ID: 17976520
    [Abstract] [Full Text] [Related]

  • 18. JAK2 V617F mutation, PRV-1 overexpression and endogenous erythroid colony formation show different coexpression patterns among Ph-negative chronic myeloproliferative disorders.
    Bellosillo B, Besses C, Florensa L, Solé F, Serrano S.
    Leukemia; 2006 Apr 01; 20(4):736-7. PubMed ID: 16453004
    [No Abstract] [Full Text] [Related]

  • 19. Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera.
    Klippel S, Strunck E, Busse CE, Behringer D, Pahl HL.
    Blood; 2002 Oct 01; 100(7):2441-8. PubMed ID: 12239154
    [Abstract] [Full Text] [Related]

  • 20. [Not just another kinase. New knowledge about myeloproliferative disease].
    Bjerrum OW.
    Ugeskr Laeger; 2006 Sep 25; 168(39):3293. PubMed ID: 17032590
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.